QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs.

作者: Luigi X. Cubeddu

DOI: 10.1097/00045391-200311000-00013

关键词: Torsades de pointesQuinidineIbutilideAnesthesiaSotalolCardiologyInternal medicineVentricular tachycardiaProcainamideAmiodaroneQT intervalMedicine

摘要: A long QT interval due to prolonged repolarization may be associated with a polymorphic ventricular tachycardia known as torsades de pointes. During marked prolongation of the action potential (long QT) early after depolarizations occur, which when propagated trigger an arrhythmia. The duration QTc is major determinant risk drug-induced torsades. Congenital syndrome, female gender, hypokalemia and use sympathomimetics increase torsades, potentiate prolonging effects drugs. Antiarrhythmics that block potassium channel prolong for (amiodarone, sotalol, quinidine, procainamide, ibutilide, disopyramide). Additionally, some macrolide fluoroquinolone antibiotics, antipsychotic antidepressant drugs, serotonin agonists triptan class, cisapride, dolasetron others have been reported or cases Drug-induced on possibility inducing fatal arrhythmias become new challenge practitioner, drug development process regulatory agencies.

参考文章(28)
Arthur J. Moss, The QT Interval and Torsade de Pointes Drug Safety. ,vol. 21, pp. 5- 10 ,(1999) , 10.2165/00002018-199921001-00002
HIEU T. TRAN, MOSES S.S. CHOW, JEFFREY KLUGER, Amiodarone Induced Torsades de Pointes with Excessive QT Dispersion Following Quinidine Induced Polymorphic Ventricular Tachycardia Pacing and Clinical Electrophysiology. ,vol. 20, pp. 2275- 2278 ,(1997) , 10.1111/J.1540-8159.1997.TB04249.X
DAN M. RODEN, PETER M. SPOONER, Inherited long QT syndromes: a paradigm for understanding arrhythmogenesis. Journal of Cardiovascular Electrophysiology. ,vol. 10, pp. 1664- 1683 ,(1999) , 10.1111/J.1540-8167.1999.TB00231.X
Y. G. Yap, Risk of torsades de pointes with non-cardiac drugs BMJ. ,vol. 320, pp. 1158- 1159 ,(2000) , 10.1136/BMJ.320.7243.1158
Andreas van de Loo, Thomas Klingenheben, Stefan H. Hohnloser, Amiodarone Therapy After Previous Sotalol-induced Torsade de Pointes: Analysis of QT Dispersion to Predict Proarrhythmia: Journal of Cardiovascular Pharmacology and Therapeutics. ,vol. 1, pp. 75- 78 ,(1996) , 10.1177/107424849600100111
Ijaz A. Khan, Long QT syndrome: diagnosis and management. American Heart Journal. ,vol. 143, pp. 7- 14 ,(2002) , 10.1067/MHJ.2002.120295
András Farkas, István Leprán, Julius Gy. Papp, Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes. Journal of Cardiovascular Pharmacology. ,vol. 39, pp. 287- 297 ,(2002) , 10.1097/00005344-200202000-00016
Jurren M. van Opstal, Marieke Schoenmakers, S. Cora Verduyn, S.H. Marieke de Groot, Jet D.M. Leunissen, Ferenc F. van der Hulst, Mirella M.C. Molenschot, Hein J.J. Wellens, Marc A. Vos, Chronic Amiodarone Evokes No Torsade de Pointes Arrhythmias Despite QT Lengthening in an Animal Model of Acquired Long-QT Syndrome Circulation. ,vol. 104, pp. 2722- 2727 ,(2001) , 10.1161/HC4701.099579